Investigation of the relationship between coagulation parameters and mortality in COVID-19 infection

Fatih Ikiz1, Ahmet Ak2

  • 1Department of Emergency Medicine, Beyhekim Training and Research Hospital, Selcuklu, Konya, Turkey.

Insights

Coagulation markers like d-dimer and fibrinogen are linked to higher mortality in COVID-19 patients. Monitoring these, along with clinical data, improves predicting patient survival outcomes.

Area of Science:

  • Medical Research
  • Hematology
  • Infectious Diseases

Background:

  • Coronavirus disease 2019 (COVID-19) poses significant mortality risks.
  • Coagulation abnormalities are frequently observed in severe COVID-19 cases.
  • Understanding predictors of mortality is crucial for patient management.

Purpose of the Study:

  • To investigate the association between specific coagulation parameters and mortality in COVID-19 patients.
  • To evaluate the predictive value of coagulation markers for COVID-19 outcomes.

Main Methods:

  • Retrospective analysis of adult COVID-19 patients admitted to the emergency department.
  • Evaluation of demographic, clinical, vital, and coagulation parameters (d-dimer, PT, aPTT, INR, fibrinogen, platelet).
  • Statistical analysis including Receiver Operating Characteristic (ROC) and regression models.

Main Results:

  • Elevated d-dimer, fibrinogen, INR, and PT were observed in elderly patients.
  • Higher d-dimer levels correlated with longer hospitalization.
  • Increased d-dimer and fibrinogen, and decreased platelet and aPTT, were associated with increased mortality.
  • ROC analysis showed significant diagnostic potential for d-dimer and fibrinogen.

Conclusions:

  • Coagulation parameters including d-dimer, fibrinogen, aPTT, and platelet count are significantly associated with COVID-19 mortality.
  • Combining coagulation markers with clinical, vital, and demographic data enhances mortality prediction accuracy.